GlassScriptPhysician profile
Ryan Summers
NPI 1467032383
$14,817.48
in general payments reported to CMS, 2019-2025
14 companies · $4,667 in 2025
The $4,667 reported for 2025 was more than what 99% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.14 · 2022: $3,744 · 2023: $4,329 · 2024: $2,036 · 2025: $4,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,373 · Food and Beverage: $1,504 · Travel and Lodging: $1,125 · Education: $30.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,373.00 |
| Food and Beverage | $1,503.91 |
| Travel and Lodging | $1,124.78 |
| Education | $30.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $9,404.92 | 2022-2025 | |
| Genentech USA, INC. | $3,678.02 | 2022-2025 | Hemlibra |
| Pfizer INC. | $1,008.79 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $225.60 | 2023-2025 | Vonvendi, Advate |
| Novo Nordisk INC | $120.35 | 2021-2025 | Alhemo |
| Csl Behring | $72.27 | 2022-2025 | Hemgenix |
| Novartis Pharmaceuticals Corporation | $71.10 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.77 | 2022-2024 | |
| Genentech, INC. | $35.77 | 2022-2025 | Hemlibra |
| Alexion Pharmaceuticals, INC. | $33.73 | 2022-2025 | Ultomiris |
| Jazz Pharmaceuticals INC. | $33.01 | 2021-2025 | |
| Chiesi USA, INC. | $29.92 | 2023-2025 | Ferriprox |
| Hema Biologics, LLC | $26.40 | 2024 | Sevenfact |
| Amgen INC. | $14.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Summers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.